Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function

Journal of Pediatrics

Volumn 163, Issue 4, 2013, Pages

  Morgan, Wayne J ^a   Wagener, Jeffrey S ^b   Yegin, Ashley ^c   Pasta, David J ^d   Millar, Stefanie J ^d   Konstan, Michael W ^e  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b Nutrition Obesity Research Center at the University of Colorado   (United States)

^c GENENTECH INC   (United States)

^d ICON Late Phase and Outcomes Research   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; COUGHING; CRACKLE; CYSTIC FIBROSIS; DETERIORATION; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SPIROMETRY;

EID: 84884672649     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2013.05.013     Document Type: Article

References (19)

1. B.P. O'Sullivan, and S.D. Freedman Cystic fibrosis Lancet 373 2009 1891 1904
2. M. Corey, H. Levison, and D. Crozier Five- to seven-year course of pulmonary function in cystic fibrosis Am Rev Respir Dis 114 1976 1085 1092
3. E. Kerem, M. Corey, R. Gold, and H. Levison Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa J Pediatri 116 1990 714 719
4. M. Corey, L. Edwards, H. Levison, and M. Knowles Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis J Pediatr 131 1997 809 814
5. M.D. Schluchter, M.W. Konstan, and P.B. Davis Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients Stat Med 21 2002 1271 1287
6. M.D. Schluchter, M.W. Konstan, M.L. Drumm, J.R. Yankaskas, and M.R. Knowles Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data Am J Respir Crit Care Med 174 2006 780 786
7. P.B. Davis, P.J. Byard, and M.W. Konstan Identifying treatments that halt progression of pulmonary disease in cystic fibrosis Pediatr Res 41 1997 161 165
8. B.S. Zemel, A.F. Jawad, S. FitzSimmons, and V.A. Stallings Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry J Pediatr 137 2000 374 380
9. M.W. Konstan, W.J. Morgan, S.M. Butler, D.J. Pasta, M.L. Craib, and S.J. Silva Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis J Pediatr 151 2007 134 139
10. V. Waters, S. Stanojevic, E.G. Atenafu, A. Lu, Y. Yau, and E. Tullis Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis Eur Respir 40 2011 61 66
11. D.B. Sanders, R.C.L. Bittner, M. Rosenfeld, L.R. Hoffman, G.J. Redding, and C.H. Goss Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation Am J Respir Crit Care Med 182 2010 627 632
12. W.J. Morgan, S.M. Butler, C.A. Johnson, A.A. Colin, S.C. FitzSimmons, and D.E. Geller Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada Pediatr Pulmonol 28 1999 231 241
13. X. Wang, D.W. Dockery, D. Wypij, M.E. Fay, and B.G. Ferris Jr. Pulmonary function between 6 and 18 years of age Pediatr Pulmonol 15 1993 75 88
14. J.L. Hankinson, J.R. Odencrantz, and K.B. Fedan Spirometric reference values from a sample of the general U.S. population Am J Respir Crit Care Med 159 1999 179 187
15. H.J. Fuchs, D.S. Borowitz, D.H. Christiansen, E.M. Morris, M.L. Nash, and B.W. Ramsey Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group N Engl J Med 331 1994 637 642
16. M. Rosenfeld, J. Emerson, J. Williams-Warren, M. Pepe, A. Smith, and A.B. Montgomery Defining a pulmonary exacerbation in cystic fibrosis J Pediatr 139 2001 359 365
17. H.R. Rabin, S.M. Butler, M.E. Wohl, D.E. Geller, A.A. Colin, and D.V. Schidlow Epidemiologic Study of Cystic Fibrosis. Pulmonary exacerbations in cystic fibrosis Pediatr Pulmonol 37 2004 400 406
18. C. Fletcher, and R. Peto The natural history of chronic airflow obstruction Br Med J 1 1977 1645 1648
19. R.A. Wise The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression Am J Med 119 2006 S4 S11